| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.00 / 0.00 |
| Exchange | NYSE |
| Div & Yield | N.A. (N.A) |
Latest News
4 Oil and Gas Stocks Fueling Up for Big Breakouts
These oil and gas stocks trading for under $10 a share are within range of triggering major breakout trades.
Short Interest Declines 17.4% For PVA
The most recent short interest data has been released by the NASDAQ for the 09/30/2015 settlement date, which shows a 4,416,843 share decrease in total short interest for Penn Virginia Corp. , to 20,987,668, a decrease of 17.39% since 09/15/2015.
Penn Virginia (PVA): Today's Weak On High Volume Stock
Trade-Ideas LLC identified Penn Virginia (PVA) as a weak on high relative volume candidate
Penn Virginia (PVA) Stock Spikes After $13 Million Asset Sale
Penn Virginia (PVA) shares are up nearly 20% after the company announced the sale of non-core assets in South Texas for $13 million.
PSivida Announces NDA For Medidur™ Now Planned Using Six-Month Efficacy Data From Both Phase III Trials; FDA Concurs
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, announced that the Company now plans to file a New Drug Application (NDA) for Medidur...
PSivida CEO To Present At Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that Dr.
PSivida Corp. Provides Company Update And Reports Fourth Quarter And FY 2015 Results
pSivida Corp. (NASDAQ: PSDV, ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today provided a Company update and announced financial results for its fourth...
PSivida CEO Invited To Speak At Surfaces In BioMaterials Foundation's BioInterface 2015 Annual Symposium
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced Dr.
PSivida Corp Announces Fourth Quarter And Fiscal Year 2015 Financial Results Release Date And Conference Call Information
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that its financial results for the fourth quarter and fiscal year...
Penn Virginia Corporation Announces Closing Of Sale Of East Texas Assets
Pro Forma Liquidity of Approximately $260 Million and Pro Forma Total Debt Ratio of 3.6 Times
Penn Virginia (PVA) Stock Closes Higher on Rising Oil Prices
Penn Virginia (PVA) stock closed in the green on Friday following oil’s second day of gains.
6 Stocks Under $10 to Trade for Breakouts
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Penn Virginia (PVA) Stock Gets Rating Downgrade at Credit Suisse
Penn Virginia (PVA) stock was downgraded to 'neutral' from 'outperform' at Credit Suisse.
Penn Virginia (PVA) Stock Falls as Oil Prices Tumble
Penn Virginia (PVA) shares are lower Monday as a higher rig count and record output from OPEC members bring oil prices down.
Penn Virginia (PVA) Stock Closes Down as Oil Prices Fall
Penn Virginia (PVA) stock is decreasing as U.S. oil prices dropped below $47 a barrel on Friday afternoon after reports showed an increase in production by OPEC.
Penn Virginia (PVA) Stock Falls After Mixed Quarterly Results
Penn Virginia (PVA) shares are lower after the company reports mixed results for the second quarter and lowers its 2015 production guidance.
Penn Virginia (PVA) Stock Higher Amid Rally in Oil Prices
Penn Virginia (PVA) stock is rising as oil prices rebound trade in the green today.